Skip to content
Screener

Cartesian Therapeutics, Inc. RNAC Q2 2026 earnings

Reported August 6, 2026 · Before market open

EPS$0.46Beat by $1.34
Revenue estimate$179.7K
EPS estimate-$0.88

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$180.0K
EPS estimate-$1.02

FAQ

When did Cartesian Therapeutics, Inc. report Q2 2026 earnings?
Cartesian Therapeutics, Inc. (RNAC) reported Q2 2026 earnings on August 6, 2026 before market open.
What were Cartesian Therapeutics, Inc.'s Q2 2026 revenue and EPS?
Cartesian Therapeutics, Inc. reported eps of $0.46 for Q2 2026.
Did Cartesian Therapeutics, Inc. beat estimates in Q2 2026?
EPS beat the consensus estimate of $-0.88 by $1.34.
How did Cartesian Therapeutics, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 8.0% from $0.50.
Where can I find Cartesian Therapeutics, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001453687-26-000100) and the 10-Q periodic report (0001453687-26-000101) directly on SEC EDGAR. The filing index links above go to sec.gov.